Swiss Life Asset Management Ltd

Position in OGN — Organon & Co.

CIK 1637689 Zurich, V8

Position in OGN

as of Jun 30, 2026 · filed Jul 29, 2026 Compact

Position Value

$450,515

+$235,595 QoQ

Shares Held

33,273

-7.3% QoQ

Ownership

0.013%

of shares outstanding

% of Portfolio

0.00%

of 13F equity value

Holder Rank

#193

of 626 holders

Holding Since

Jun 2021

11 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

Swiss Life Asset Management Ltd holds $1,469,110,886 across 10 Drug Manufacturers - General names. OGN ranks #10 (0.0% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	LLY	ELI LILLY & Co	357,284	$428,537,182
2	JNJ	Johnson & Johnson	1,192,228	$302,790,144
3	ABBV	AbbVie Inc.	680,811	$171,319,279
4	MRK	Merck & Co., Inc.	1,305,364	$167,739,274
5	PFE	Pfizer Inc	6,943,719	$167,204,752
6	BMY	Bristol Myers Squibb Co	1,414,008	$81,475,140
7	AMGN	Amgen Inc	209,837	$75,986,174
8	GILD	Gilead Sciences, Inc.	525,655	$66,411,252

11 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$450,515	33,273	-7.3%	Shares	Defined	2026-07-29
2026-03-31	$214,920	35,880	+7.6%	Shares	Defined	2026-05-14
2025-12-31	$239,097	33,347	+189.3%	Shares	Sole	2026-02-04
2025-09-30	$123,086	11,525	-35.4%	Shares	Defined	2025-12-02
2022-12-31	$498,326	17,842	+1.2%	Shares	Sole	2025-12-09
2022-09-30	$412,705	17,637	+3.6%	Shares	Defined	2025-12-09
2022-06-30	$574,559	17,024	+72.7%	Shares	Sole	2025-12-09
2022-03-31	$344,269	9,856	-19.4%	Shares	Defined	2025-12-09
2021-12-31	$372,281	12,226	-0.2%	Shares	Sole	2025-12-29
2021-09-30	$401,546	12,246	-47.9%	Shares	Defined	2025-12-29
2021-06-30	$710,837	23,491	—	Shares	Sole	2025-12-29
No filing history on record for this holder in this stock.